Mangoceuticals Partners with Lilly & Novo Nordisk for Direct Weight-Loss Meds

Mangoceuticals partners with Eli Lilly and Novo Nordisk, offering popular weight-loss medications directly to customers via their online platform. This collaboration, along with the launch of MangoRx Direct and PeachesRx Direct programs, aims to simplify access to GLP-one medications like Zepbound and Wegovy. This direct-to-consumer approach marks a significant shift in the pharmaceutical industry, potentially making these treatments more accessible to a broader audience.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.